Trials / Completed
CompletedNCT02418390
The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate the efficacy and safety of prophylactic central lymph node dissection in papillary thyroid carcinoma.
Detailed description
The aim of this study is to investigate the efficacy and safety of prophylactic central lymph node dissection in papillary thyroid carcinoma. Primary outcome is the surgical completeness, recurrence rate, and successful ablation rate. Secondary outcomes are the incidence of postoperative complications and PTC stage. The enrolled patients were randomly assigned to control group and intervention group (1:1 allocation).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | prophylactic central lymph node dissection | dissection of level VI compartment by AAHNS (American association of head and neck surgeons) classification |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2020-10-08
- Completion
- 2020-10-08
- First posted
- 2015-04-16
- Last updated
- 2022-06-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02418390. Inclusion in this directory is not an endorsement.